Fatty acid desaturase 1 drives esophageal cancer via M1 macrophage ferroptosis and lipid metabolism remodeling
World Journal of Gastrointestinal Oncology · 15.11.2026 · 18 (11)
DOI: 10.4251/wjgo.124110 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastrointestinal Oncology, online erschienen am 15.11.2026. Verfasst von Qian-Cheng Du und 4 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Esophageal cancer is a major health challenge with a poor prognosis. The tumor microenvironment, particularly the role of immune cells such as macrophages, is critical in cancer progression. The lipid metabolism enzyme fatty acid desaturase 1 (FADS1) is involved in various cancers, but its specific function in the immune regulation of esophageal cancer is unclear. AIM To explore whether FADS1 promotes esophageal cancer progression by remodeling the phospholipid metabolism, facilitating lipid raft assembly and triggering ferroptosis in M1 macrophages. METHODS We conducted a bidirectional Mendelian randomization study to identify ferroptosis-related genes linked to esophageal cancer susceptibility. Comprehensive bioinformatics analyses were performed using public transcriptomic and single-cell RNA sequencing datasets. Protein localization was examined via immunofluorescence in clinical specimens. Laboratory experiments involved the genetic manipulation of Tamm-Horsfall protein-1-derived M1 macrophages, measurement of lipid oxidation products, coculture assays, phospholipid supplementation, and disruption of lipid rafts. Virtual gene knockout and artificial intelligence-guided drug screening were also employed. RESULTS FADS1 was identified as a causal factor for esophageal cancer development and was overexpressed in tumor tissues, particularly in M1-polarized macrophages. Genetic inhibition of FADS1 expression in M1 macrophages reduced lipid peroxidation and ferroptosis, enhancing their cancer-killing ability in coculture with esophageal cancer cells. Mechanistically, FADS1 promoted the accumulation of 1-palmitoyl-2-stearoyl-glycerophosphocholine (16:0/18:0), which facilitated lipid raft assembly and triggered ferroptosis in M1 macrophages. Computational analysis revealed an immune-related gene network controlled by FADS1. The compound BRD-K95779464 was identified as a promising FADS1 inhibitor. CONCLUSION FADS1 promotes esophageal cancer progression by reprogramming the phospholipid metabolism to assemble lipid rafts, which triggers ferroptosis in M1 macrophages. This study identifies FADS1 as a potential therapeutic target for esophageal cancer immunotherapy.
Zitieren
APA
Du, Q., Bai, Y., Zhou, D., Yu, H., & Nian, H. (2026). Fatty acid desaturase 1 drives esophageal cancer via M1 macrophage ferroptosis and lipid metabolism remodeling. World Journal of Gastrointestinal Oncology, 18(11). https://doi.org/10.4251/wjgo.124110
Vancouver
Du Q, Bai Y, Zhou D, Yu H, Nian H. Fatty acid desaturase 1 drives esophageal cancer via M1 macrophage ferroptosis and lipid metabolism remodeling. World Journal of Gastrointestinal Oncology. 2026;18(11). doi:10.4251/wjgo.124110
BibTeX
@article{Du2026,
author = {Du, Qian-Cheng and Bai, Yu and Zhou, De-Hua and Yu, Hua and Nian, Hui},
title = {Fatty acid desaturase 1 drives esophageal cancer via M1 macrophage ferroptosis and lipid metabolism remodeling},
journal = {World Journal of Gastrointestinal Oncology},
year = {2026},
volume = {18},
number = {11},
doi = {10.4251/wjgo.124110}
}
EUVIMED